Appel GRJ, D'Agati V: The Kidney. 2007, Philadelphia, PA: Saunders Elsevier, 8
Google Scholar
US Renal Data System: Incidence of reported ESRD, by primary diagnosis. 2002-2006 Combined. 2008
Google Scholar
Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K: Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis. 2003, 62: 435-439. 10.1136/ard.62.5.435.
Article
PubMed Central
CAS
PubMed
Google Scholar
Faurschou M, Starklint H, Halberg P, Jacobsen S: Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol. 2006, 33: 1563-1569.
PubMed
Google Scholar
Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP: The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol. 1994, 21: 2046-2051.
CAS
PubMed
Google Scholar
Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN: Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2005, 16: 467-473. 10.1681/ASN.2004080658.
Article
CAS
PubMed
Google Scholar
Li Y, Tucci M, Narain S, Barnes EV, Sobel ES, Segal MS, Richards HB: Urinary biomarkers in lupus nephritis. Autoimmun Rev. 2006, 5: 383-388. 10.1016/j.autrev.2005.10.006.
Article
CAS
PubMed
Google Scholar
Enghard P, Riemekasten G: Immunology and the diagnosis of lupus nephritis. Lupus. 2009, 18: 287-290. 10.1177/0961203308099632.
Article
CAS
PubMed
Google Scholar
Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, Mackay M, Aranow C, Putterman C, Mohan C: Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol. 2007, 179: 7166-7175.
Article
CAS
PubMed
Google Scholar
Ikeda Y, Fujimoto T, Ameno M, Shiiki H, Dohi K: Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus. 1998, 7: 347-354. 10.1191/096120398678920172.
Article
CAS
PubMed
Google Scholar
Ilic T, Mitic I, Durdevic-Mirkovic T, Vuckovic B, Milic B, Popovic M: Correlation between sera levels of sICAM-1 and sVCAM-1 and severity of kidney lesions in patients with lupus nephritis. Med Pregl. 2007, 60 (Suppl 2): 128-132.
PubMed
Google Scholar
Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, Takahashi Y, Sasaki T, Furuichi K, Segawa C, Hisada Y, Ohta S, Takasawa K, Kobayashi K, Matsushima K: Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 1996, 49: 761-767. 10.1038/ki.1996.105.
Article
CAS
PubMed
Google Scholar
Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y: Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol. 2002, 20: 403-406.
CAS
PubMed
Google Scholar
Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A: Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest. 1995, 73: 804-809.
CAS
PubMed
Google Scholar
Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA: Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis. 2007, 65: 187-193.
PubMed
Google Scholar
Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999, 190: 1813-1824. 10.1084/jem.190.12.1813.
Article
PubMed Central
CAS
PubMed
Google Scholar
Marks SD, Williams SJ, Tullus K, Sebire NJ: Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant. 2008, 23: 3521-3526. 10.1093/ndt/gfn270.
Article
CAS
PubMed
Google Scholar
Wuthrich RP: Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992, 42: 903-914. 10.1038/ki.1992.367.
Article
CAS
PubMed
Google Scholar
Zhu J, Liu X, Xie C, Yan M, Yu Y, Sobel ES, Wakeland EK, Mohan C: T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest. 2005, 115: 1869-1878. 10.1172/JCI23049.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pizarro S, Monarrez Espino J, Ruiz A, Jara LJ, Nava A, Riebeling-Navarro C: Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement. Rev Alerg Mex. 2007, 54: 189-195.
PubMed
Google Scholar
Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG: Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol. 1994, 97: 439-444.
Article
PubMed Central
CAS
PubMed
Google Scholar
Teramoto K, Negoro N, Kitamoto K, Iwai T, Iwao H, Okamura M, Miura K: Microarray analysis of glomerular gene expression in murine lupus nephritis. J Pharmacol Sci. 2008, 106: 56-67. 10.1254/jphs.FP0071337.
Article
CAS
PubMed
Google Scholar
Petri M, Magder L: Classification criteria for systemic lupus erythematosus: a review. Lupus. 2004, 13: 829-837. 10.1191/0961203304lu2019oa.
Article
CAS
PubMed
Google Scholar
Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004, 15: 241-250. 10.1097/01.ASN.0000108969.21691.5D.
Article
PubMed
Google Scholar
Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984, 25: 689-695. 10.1038/ki.1984.75.
Article
PubMed
Google Scholar
Singh S, Saxena R: Lupus nephritis. Am J Med Sci. 2009, 337: 451-460. 10.1097/MAJ.0b013e3181907b3d.
Article
PubMed
Google Scholar
Houssiau FA: Management of lupus nephritis: an update. J Am Soc Nephrol. 2004, 15: 2694-2704. 10.1097/01.ASN.0000140218.77174.0A.
Article
PubMed
Google Scholar
Cameron JS: Lupus nephritis. J Am Soc Nephrol. 1999, 10: 413-424.
CAS
PubMed
Google Scholar
Font J, Torras A, Cervera R, Darnell A, Revert L, Ingelmo M: Silent renal disease in systemic lupus erythematosus. Clin Nephrol. 1987, 27: 283-288.
CAS
PubMed
Google Scholar
Zabaleta-Lanz M, Vargas-Arenas RE, Tapanes F, Daboin I, Atahualpa Pinto J, Bianco NE: Silent nephritis in systemic lupus erythematosus. Lupus. 2003, 12: 26-30. 10.1191/0961203303lu259oa.
Article
CAS
PubMed
Google Scholar
Wada Y, Ito S, Ueno M, Nakano M, Arakawa M, Gejyo F: Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis. Nephron Clin Pract. 2004, 98: c105-c111. 10.1159/000081551.
Article
PubMed
Google Scholar
Bajaj S, Albert L, Gladman DD, Urowitz MB, Hallett DC, Ritchie S: Serial renal biopsy in systemic lupus erythematosus. J Rheumatol. 2000, 27: 2822-2826.
CAS
PubMed
Google Scholar
Arrizabalaga P, Sole M, Iglesias C, Escaramis G, Ascaso C: Renal expression of ICAM-1 and VCAM-1 in ANCA-associated glomerulonephritis - are there differences among serologic subgroups?. Clin Nephrol. 2006, 65: 79-86.
Article
CAS
PubMed
Google Scholar
Abd-Elkareem MI, Al Tamimy HM, Khamis OA, Abdellatif SS, Hussein MR: Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin Exp Nephrol. 2010, 14: 548-557. 10.1007/s10157-010-0322-z.
Article
CAS
PubMed
Google Scholar
Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z: Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton). 2012, 17: 338-345. 10.1111/j.1440-1797.2012.01575.x.
Article
CAS
Google Scholar
Honkanen E, von Willebrand E, Teppo AM, Tornroth T, Gronhagen-Riska C: Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis. Kidney Int. 1998, 53: 909-917.
Article
CAS
PubMed
Google Scholar
Saxena V, Lienesch DW, Zhou M, Bommireddy R, Azhar M, Doetschman T, Singh RR: Dual roles of immunoregulatory cytokine TGF-β in the pathogenesis of autoimmunity-mediated organ damage. J Immunol. 2008, 180: 1903-1912.
Article
PubMed Central
CAS
PubMed
Google Scholar